North American Neuroendocrine Tumor Society

Analysis

North American Neuroendocrine Tumor Society is a registered charity in United States, based in Albany, NY. It received its IRS tax-exemption ruling in February 2007, 19 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, North American Neuroendocrine Tumor Society reported income of $1.1m and spending of $1.4m, spending 126% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $1.2m to $1.1m (-7.6%), an average of -2.0% a year. The sharpest change came in the year to December 2022, when income rose by 66%. Over the whole period it spent 86% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, North American Neuroendocrine Tumor Society sits at the 65th percentile: it is larger than about 65% of them. Against every charity in United States with reported income it ranks in the 80th percentile, and in the 76th percentile within NY. Charities of a similar size with the same main cause include Healthy Black Families ($1.1m), Blindness-Learning in New Dimensions Inc ($1.1m) and West Side Hatzoloh ($1.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 11% and program service revenue 85% of the total. At year end it held assets of $1.5m against liabilities of $119k, net assets of $1.4m.